Cutaneous Manifestations of HIV-a Detailed Study of Morphological Variants, Markers of Advanced Disease, and the Changing Spectrum

Overview

Journal Med J Armed Forces India

Specialty General Medicine

Date 2014 Mar 27

PMID 24669034

Citations 4

Authors

Biju Vasudevan

Amitabh Sagar

Ashish Bahal

Ap Mohanty

Affiliations

Soon will be listed here.

Abstract

Background: Cutaneous manifestations are early and easily identifiable markers of human immunodeficiency virus (HIV) infection. They can help in predicting severity and progress of the disease and can be correlated well with CD4 counts. This study was undertaken to study the cutaneous manifestations of HIV infection and to correlate them with CD4 counts. It also aimed to study the changing spectrum of these manifestations and describe cutaneous manifestations seen in advanced disease.

Method: A total of 234 HIV-positive patients not on anti-retroviral therapy, who attended the outpatient department or were admitted as inpatients at Military Hospital, Shillong during the period between May 2008 and October 2009 were included. Cutaneous, mucosal, and genitourinary manifestations in these patients were studied in detail and were correlated with CD4 counts.

Results: Infections were the most common group of mucocutaneous manifestations, while onychomycosis was the commonly observed individual manifestation. A different set of cutaneous markers for advanced HIV disease was observed and new parameters for therapy were also arrived at.

Conclusion: Specific morphological variants of cutaneous markers may provide a better clue to early diagnosis of HIV and can help in diagnosing advanced stages of the disease. Fresh cutaneous markers are required for indicating cut-off levels of CD4 count at 350/μL for starting therapy.

Citing Articles

The prevalence and spectrum of mucocutaneous disease in South African people living with HIV and accessing care at a district-level hospital.

Claasens S, Kannenberg S, Jordaan H, Moxley K, Smith R, de Wet J South Afr J HIV Med. 2020; 21(1):1154.

PMID: 33354365 PMC: 7736648. DOI: 10.4102/sajhivmed.v21i1.1154.

Prevalence of oromucosal lesions in HIV positive patients receiving haart-A prospective clinical study.

Maloth S, Shrinivas T, Krishna Pramod B, Nagarathna P J Family Med Prim Care. 2020; 9(9):4821-4825.

PMID: 33209807 PMC: 7652119. DOI: 10.4103/jfmpc.jfmpc_881_20.

Dermatological Manifestations of HIV/AIDS Individuals in Shiraz, South of Iran.

Davarpanah M, Motazedian N, Jowkar F J Glob Infect Dis. 2018; 10(2):80-83.

PMID: 29910568 PMC: 5987376. DOI: 10.4103/0974-777X.233000.

Dermatological manifestations in human immunodeficiency virus infected patients: Morphological spectrum with CD4 correlation.

Chawhan S, Bhat D, Solanke S Indian J Sex Transm Dis AIDS. 2013; 34(2):89-94.

PMID: 24339458 PMC: 3841677. DOI: 10.4103/0253-7184.120538.

References

Mathes B, Douglass M . Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1985; 13(6):947-51. DOI: 10.1016/s0190-9622(85)70243-5. View

Kaviarasan P, Jaisankar T, Thappa D, Sujatha S . Clinical variations in dermatophytosis in HIV infected patients. Indian J Dermatol Venereol Leprol. 2007; 68(4):213-6. View

Ranganathan K, Umadevi M, Saraswathi T, Kumarasamy N, Solomon S, Johnson N . Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients. Ann Acad Med Singap. 2004; 33(4 Suppl):37-42. View

Dever L, Matta J . Digital clubbing in HIV-infected patients: an observational study. AIDS Patient Care STDS. 2008; 23(1):19-22. DOI: 10.1089/apc.2008.0102. View

Goodman D, Teplitz E, Wishner A, Klein R, BURK P, Hershenbaum E . Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol. 1987; 17(2 Pt 1):210-20. DOI: 10.1016/s0190-9622(87)70193-5. View

Boonen A, Schrey G, van der Linden S . Clubbing in human immunodeficiency virus infection. Br J Rheumatol. 1996; 35(3):292-4. DOI: 10.1093/rheumatology/35.3.292. View

Hollander H, Greenspan D, Stringari S, Greenspan J, Schiodt M . Hairy leukoplakia and the acquired immunodeficiency syndrome. Ann Intern Med. 1986; 104(6):892. DOI: 10.7326/0003-4819-104-6-892_1. View

Sadick N, Kaplan M, Pahwa S, Sarngadharan M . Unusual features of scabies complicating human T-lymphotropic virus type III infection. J Am Acad Dermatol. 1986; 15(3):482-6. DOI: 10.1016/s0190-9622(86)70197-7. View

Sharma Y, Sawhney M, Bhakuni D, Gera V . Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting. Med J Armed Forces India. 2016; 60(3):239-43. PMC: 4923211. DOI: 10.1016/S0377-1237(04)80054-6. View

10.

Goldstein B, Berman B, Sukenik E, Frankel S . Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS. J Am Acad Dermatol. 1997; 36(2 Pt 1):262-4. DOI: 10.1016/s0190-9622(97)70295-0. View

11.

Dompmartin D, Dompmartin A, Deluol A, Grosshans E, Coulaud J . Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients. Int J Dermatol. 1990; 29(5):337-9. DOI: 10.1111/j.1365-4362.1990.tb04755.x. View

12.

Brancato L, Itescu S, Skovron M, Solomon G, Winchester R . Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter's syndrome and related disorders associated with HIV infection. Rheumatol Int. 1989; 9(3-5):137-41. DOI: 10.1007/BF00271870. View

13.

Lifson A, Hilton J, Westenhouse J, Canchola A, Samuel M, Katz M . Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS. 1994; 8(1):73-9. DOI: 10.1097/00002030-199401000-00011. View

14.

Uthayakumar S, Nandwani R, Drinkwater T, Nayagam A, Darley C . The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br J Dermatol. 1997; 137(4):595-8. DOI: 10.1111/j.1365-2133.1997.tb03793.x. View

15.

Coldiron B, Bergstresser P . Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol. 1989; 125(3):357-61. View

16.

Rajagopalan B, Jacob M, George S . Skin lesions in HIV-positive and HIV-negative patients in south India. Int J Dermatol. 1996; 35(7):489-92. DOI: 10.1111/j.1365-4362.1996.tb01663.x. View

17.

Samet J, Muz P, Cabral P, Jhamb K, Suwanchinda A, Freedberg K . Dermatologic manifestations in HIV-infected patients: a primary care perspective. Mayo Clin Proc. 1999; 74(7):658-60. DOI: 10.4065/74.7.658. View

18.

Surjushe A, Kamath R, Oberai C, Saple D, Thakre M, Dharmshale S . A clinical and mycological study of onychomycosis in HIV infection. Indian J Dermatol Venereol Leprol. 2007; 73(6):397-401. DOI: 10.4103/0378-6323.37057. View

19.

Nair S, Moorty K, Suprakasan S . Clinico-epidemiological study of HIV patients in Trivandrum. Indian J Dermatol Venereol Leprol. 2007; 69(2):100-3. View

20.

Sehgal V, Jain S . Onychomycosis: clinical perspective. Int J Dermatol. 2000; 39(4):241-9. DOI: 10.1046/j.1365-4362.2000.00812.x. View